JBIO Jade Biosciences, Inc.
$14.74▲ +1.66%
Healthcare
Other
After hours
$14.74▲ +0.00%
Oct 27, 4:01 PM ET
Volume 652.9K
Avg Volume (10D) 885.2K
Key Metrics & Fundamentals
Market Cap
$937.43M
P/E Ratio
–
Div Yield
0.00%
52W Range
8.36 - 28.00
% vs 50 MA
-13.18%
% vs 200 MA
-19.18%
RSI-14
46.8
MACD Histogram
+0.3200
Beta (1Y vs SPY)
1.25
Free Cash Flow
-$43.66M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$58.91M
COGS
–
Operating Exp
$58.92M
Operating Income
-$58.92M
EBIT
-$58.92M
Pretax Income
-$55.75M
Net Income
-$55.77M
EPS (Diluted)
-0.76
Price & Volume History
Loading chart…
Recent News
Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026
GlobeNewswire · Oct 21, 2026 7:00 AM ET
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026
GlobeNewswire · Sep 30, 2026 7:00 AM ET
Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says
MT Newswires · Sep 4, 2026 11:17 AM ET
Jade Biosciences to Participate in Upcoming Conferences
GlobeNewswire · Sep 1, 2026 7:00 AM ET
Wedbush Adjusts Price Target on Jade Biosciences to $47 From $45, Keeps Outperform Rating
MT Newswires · Aug 10, 2026 11:43 AM ET
Jade Biosciences' Q2 Loss Narrows
MT Newswires · Aug 10, 2026 7:25 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See JBIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.